EDAP Reports Second Quarter 2022 Results
24 août 2022 16h35 HE
|
EDAP TMS S.A.
Announced Focal One® HIFU reimbursement raised to urology APC Level 6 under CMS Outpatient Prospective Payment System (OPPS) proposed rule for CY23Second quarter 2022 total revenue of approximately...
EDAP TMS SA to Announce Second Quarter 2022 Financial Results on August 24th, 2022
03 août 2022 08h00 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, August 25th at 8:30 am EDT LYON, France, August 3, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Proposed Rule for CY23
18 juil. 2022 07h00 HE
|
EDAP TMS S.A.
Proposed rule, if adopted for CY23, would increase Medicare Payment for a Focal One HIFU procedure completed on an outpatient basis at a hospital LYON, France, July 18, 2022 -- EDAP TMS SA (Nasdaq:...
EDAP’s Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Congresses
28 juin 2022 09h00 HE
|
EDAP TMS S.A.
LYON, France, June 28, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced its participation to two major forthcoming...
EDAP holds a Symposium at 6th European Endometriosis Congress
14 juin 2022 08h00 HE
|
EDAP TMS S.A.
LYON, France, June 14, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Prof. Gil Dubernard, Head of the Gynecology...
EDAP Announces Multiple Oral Presentations at the 21st International Symposium on Therapeutic Ultrasound
06 juin 2022 08h00 HE
|
EDAP TMS S.A.
LYON, France, June 6, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that three oral presentations will be delivered on its...
EDAP Reports First Quarter 2022 Results
17 mai 2022 16h35 HE
|
EDAP TMS S.A.
First quarter 2022 revenue of approximately EUR 13.0 million (USD 14.5 million), an increase of 26% as compared to EUR 10.3 million (USD 12.4 million) for the first quarter 2021Four Focal One units...
EDAP TMS SA to Announce First Quarter 2022 Financial Results on May 17, 2022
10 mai 2022 08h30 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on, Wednesday, May 18th at 8:30 am EDT LYON, France, May 10, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)
05 mai 2022 08h30 HE
|
EDAP TMS S.A.
AUA is the largest annual gathering of urologists worldwide LYON, France, May 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,...
EDAP Provides Corporate Update on US Focal One® Installation Growth
12 avr. 2022 08h00 HE
|
EDAP TMS S.A.
Company announces Focal One® placements at three renowned academic institutions in March LYON, France, April 12, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in...